Kevin Mannix joined BeiGene in 2021 as Senior Vice President, Investor Relations.

Mr. Mannix has built a career around extensive global investor relations experience, having joined BeiGene from Teva Pharmaceuticals Industries Ltd., where he served as Senior Vice President of Investor Relations. Mr. Mannix joined Teva as the first dedicated investor relations professional in North America and held positions of increasing responsibility over his 18 years with the company. Prior to Teva, Mr. Mannix spent nine years at investor relations and financial communications consultancies including Thomson Financial/Carson and Citigate Dewe Rogerson.

Mr. Mannix holds a Bachelor of Arts degree in history from Siena College in Albany, New York, and is working toward an M.S. in Finance from Saint Joseph’s University in Philadelphia.